Alvotech Says Adalimumab Story Is ‘Still Being Written’ Ahead Of ‘Critical’ Inspection
Company Confirms It Has Resubmitted Teva-Partnered AVT02 Humira Rival In US
• By David Wallace
The history of US Humira biosimilars is still to be written, Alvotech says • Source: Shutterstock 
